TY - JOUR
T1 - Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype
AU - Knowles, Michael R.
AU - Ostrowski, Lawrence E.
AU - Leigh, Margaret W.
AU - Sears, Patrick R.
AU - Davis, Stephanie D.
AU - Wolf, Whitney E.
AU - Hazucha, Milan J.
AU - Carson, Johnny L.
AU - Olivier, Kenneth N.
AU - Sagel, Scott D.
AU - Rosenfeld, Margaret
AU - Ferkol, Thomas W.
AU - Dell, Sharon D.
AU - Milla, Carlos E.
AU - Randell, Scott H.
AU - Yin, Weining
AU - Sannuti, Aruna
AU - Metjian, Hilda M.
AU - Noone, Peadar G.
AU - Noone, Peter J.
AU - Olson, Christina A.
AU - Patrone, Michael V.
AU - Dang, Hong
AU - Lee, Hye Seung
AU - Hurd, Toby W.
AU - Gee, Heon Yung
AU - Otto, Edgar A.
AU - Halbritter, Jan
AU - Kohl, Stefan
AU - Kircher, Martin
AU - Krischer, Jeffrey
AU - Bamshad, Michael J.
AU - Nickerson, Deborah A.
AU - Hildebrandt, Friedhelm
AU - Shendure, Jay
AU - Zariwala, Maimoona A.
PY - 2014/3/15
Y1 - 2014/3/15
N2 - Rationale: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous recessive disorder of motile cilia, but the genetic cause is not defined for all patients with PCD. Objectives: To identify disease-causingmutations in novel genes, we performed exome sequencing, follow-up characterization, mutation scanning, and genotype-phenotype studies in patients with PCD. Methods: Whole-exome sequencing was performed using NimbleGen capture and Illumina HiSeq sequencing. Sanger-based sequencing was used for mutation scanning, validation, and segregation analysis. Measurements and Main Results: We performed exome sequencing on an affected sib-pair with normal ultrastructure in more than 85% of cilia. A homozygous splice-site mutation was detected in RSPH1 in both siblings; parents were carriers. Screening RSPH1 in 413 unrelated probands, including 325 with PCD and 88 with idiopathic bronchiectasis, revealed biallelic loss-of-function mutations in nine additional probands. Five affected siblings of probands in RSPH1 families harbored the familial mutations. The 16 individuals with RSPH1 mutations had some features of PCD; however, nasal nitric oxide levels were higher than in patients with PCD with other gene mutations (98.3 vs. 20.7 nl/min; P , 0.0003). Additionally, individuals with RSPH1 mutations had a lower prevalence (8 of 16) of neonatal respiratory distress, and later onset of daily wet cough than typical for PCD, and better lung function (FEV1), compared with 75 age- and sex-matched PCD cases (73.0 vs. 61.8, FEV1 % predicted; P = 0.043). Cilia from individuals with RSPH1 mutations had normal beat frequency (6.16Hz at 258C), but an abnormal, circular beat pattern. Conclusions: The milder clinical disease and higher nasal nitric oxide in individuals with biallelic mutations in RSPH1 provides evidence of a unique genotype-phenotype relationship in PCD, and suggests that mutations in RSPH1 may be associated with residual ciliary function.
AB - Rationale: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous recessive disorder of motile cilia, but the genetic cause is not defined for all patients with PCD. Objectives: To identify disease-causingmutations in novel genes, we performed exome sequencing, follow-up characterization, mutation scanning, and genotype-phenotype studies in patients with PCD. Methods: Whole-exome sequencing was performed using NimbleGen capture and Illumina HiSeq sequencing. Sanger-based sequencing was used for mutation scanning, validation, and segregation analysis. Measurements and Main Results: We performed exome sequencing on an affected sib-pair with normal ultrastructure in more than 85% of cilia. A homozygous splice-site mutation was detected in RSPH1 in both siblings; parents were carriers. Screening RSPH1 in 413 unrelated probands, including 325 with PCD and 88 with idiopathic bronchiectasis, revealed biallelic loss-of-function mutations in nine additional probands. Five affected siblings of probands in RSPH1 families harbored the familial mutations. The 16 individuals with RSPH1 mutations had some features of PCD; however, nasal nitric oxide levels were higher than in patients with PCD with other gene mutations (98.3 vs. 20.7 nl/min; P , 0.0003). Additionally, individuals with RSPH1 mutations had a lower prevalence (8 of 16) of neonatal respiratory distress, and later onset of daily wet cough than typical for PCD, and better lung function (FEV1), compared with 75 age- and sex-matched PCD cases (73.0 vs. 61.8, FEV1 % predicted; P = 0.043). Cilia from individuals with RSPH1 mutations had normal beat frequency (6.16Hz at 258C), but an abnormal, circular beat pattern. Conclusions: The milder clinical disease and higher nasal nitric oxide in individuals with biallelic mutations in RSPH1 provides evidence of a unique genotype-phenotype relationship in PCD, and suggests that mutations in RSPH1 may be associated with residual ciliary function.
UR - http://www.scopus.com/inward/record.url?scp=84896534982&partnerID=8YFLogxK
U2 - 10.1164/rccm.201311-2047OC
DO - 10.1164/rccm.201311-2047OC
M3 - Journal articles
C2 - 24568568
AN - SCOPUS:84896534982
SN - 1073-449X
VL - 189
SP - 707
EP - 717
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 6
ER -